Anavex Life Sciences
AVXL
AVXL
148 hedge funds and large institutions have $383M invested in Anavex Life Sciences in 2021 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 52 increasing their positions, 31 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
1.86% more ownership
Funds ownership: 27.21% → 29.07% (+1.9%)
4% more capital invested
Capital invested by funds: $370M → $383M (+$13.2M)
Holders
148
Holding in Top 10
–
Calls
$19.2M
Puts
$15.2M
Top Buyers
| 1 | +$14.4M | |
| 2 | +$6.91M | |
| 3 | +$4.73M | |
| 4 |
Barclays
London,
United Kingdom
|
+$3.33M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$2.02M |
Top Sellers
| 1 | -$5.75M | |
| 2 | -$2.71M | |
| 3 | -$2.6M | |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$2.21M |
| 5 |
KPWS
Kestra Private Wealth Services
Austin,
Texas
|
-$1.8M |